MedTrace Logo

Subjective and Objective Methods of Assessing Walking Limitation Due to Claudication

NCT01484509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2012-05-15

No results posted yet for this study

Summary

Leg artery disease is a common condition in which fatty deposits develop in the blood vessels that supply the legs. Many patients with leg artery disease experience a cramp-like leg pain during walking that is relieved by rest; this is called intermittent claudication. To help determine the severity of leg artery disease, patients may be questioned about how far they can walk before claudication pain forces them to stop. However, this information is usually of limited use because most patients poorly estimate their walking capacity. The investigators have developed a simple questionnaire to help estimate walking capacity in patients with leg artery disease. The purpose of this study is to test the validity and reliability of this questionnaire. By validity, the investigators mean the extent to which the questionnaire measures what it is supposed to measure (walking capacity). By reliability, the investigators mean the extent to which the questionnaire produces the same results over time when completed on two different days.

The investigators hypothesise that the investigators simple questionnaire will be valid and reliable.

Conditions

  • Intermittent Claudication

Sponsors & Collaborators

  • Sheffield Hallam University

    collaborator OTHER

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Imperial College London

    collaborator OTHER

  • Sheffield Teaching Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Garry A Tew, PhD · Sheffield Hallam University

  • Pierre Abraham, MD, PhD · University Hospital of Angers, France

  • Shah Nawaz, MD · Sheffield Teaching Hospitals NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01484509 on ClinicalTrials.gov